Eriso, Feleke (2023) Genome, Validity of Adjuvants & Misterming Adjuvants as Cancer Vaccines. European Journal of Biology and Medical Science Research, 11 (3). pp. 64-84. ISSN 2053-406X, 2053-4078
![[thumbnail of Genome.pdf]](https://tudr.org/style/images/fileicons/text.png)
Text
Genome.pdf - Published Version
Restricted to Registered users only
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (953kB) | Request a copy
Abstract
The term adjuvant comes from the Latin word ’adjuvare’ meaning help. Thus, adjuvants help vaccines improve the antigen-specific immune response by inducing pathogen-associated molecular patterns (PAMPs) that can activate various pattwern recognition receptors (PRRs) of innate immune cells.The key objective of this study is to verify that what are called therapeutic vaccines of cancers are totally the types of adjuvants that increase the immunogenicity of neoantigens (autovaccines) found on surfaces of cancered cells such as those of metastatic tumors. The contents of Figures & Table were designed to serve as Results derived from the targetful and strategic methods implemented, under the title of Methodology & Results. The contents of Figures & Table under the title of Methodology & Results represent the result. Represented by 31 conclusive statements listed (enumerated) under the conclusion section of this paper.
| Item Type: | Article |
|---|---|
| Subjects: | Q Science > Q Science (General) |
| Depositing User: | Professor Mark T. Owen |
| Date Deposited: | 09 Aug 2023 04:01 |
| Last Modified: | 09 Aug 2023 04:01 |
| URI: | https://tudr.org/id/eprint/2083 |
Actions (login required)
- View Item
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)